You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 HPV detection and type distribution in histologically confirmed ICC tissue samples from New Zealand women (N a= 227)

From: Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand

Histological diagnosis/HPV type All ICC types (N = 227) ICC subtypes
ADC/ASC (N = 68) SCC (N = 159)
  nb %c(95% CI) n % (95% CI)d n % (95% CI)
HPV positive 201 88.5 (83.7–92.4) 53 77.9 (66.2–87.1) 148 93.1 (88.0–96.5)
Any high-risk HPV 198 87.2 (82.2–91.3) 53 77.9 (66.2–87.1) 145 91.2 (85.7–95.1)
HPV-16 116 51.1 (44.4–57.8) 27 39.7 (28.0–52.3) 89 56.0 (47.9–63.8)
HPV-18 47 20.7 (15.6–26.6) 24 35.3 (24.1–47.8) 23 14.5 (9.4–20.9)
HPV-31 9 4.0 (1.8–7.4) 0 0.0 (0.0–5.3) 9 5.7 (2.6–10.5)
HPV-45 7 3.1 (1.2–6.3) 2 2.9 (0.4–10.2) 5 3.1 (1.0–7.2)
HPV-52 7 3.1 (1.2–6.3) 0 0.0 (0.0–5.3) 7 4.4 (1.8–8.9)
HPV-59 5 2.2 (0.7–5.1) 0 0.0 (0.0–5.3) 5 3.1 (1.0–7.2)
HPV-33 4 1.8 (0.5–4.5) 1 1.5 (0.0–7.9) 3 1.9 (0.4–5.4)
Other 17* 7.5 (4.4–11.7) 1 1.5 (0.0–7.9) 16 10.1 (5.9–15.8)
Any low-risk HPV 2 0.9 (0.1–3.1) 0 0.0 (0.0–5.3) 2 1.3 (0.2–4.5)
  1. anumber of women with the corresponding diagnosis.
  2. bnumber of women in each category.
  3. cpercentage of women in each category.
  4. dexact 95% confidence interval.
  5. ICC: Invasive cervical cancer; ADC: Adenocarcinoma; ASC: Adenosquamous carcinoma; SCC: Squamous cell carcinoma.
  6. *Includes 2 HPV types unidentifiable by LiPA.
  7. Other refers to HPV-35 (3 ICC samples), 39 (3), 51 (2), 56 (3), 66 (1), 68 (3) and –X (2 HPV types unidentifiable by LiPA).